A Clinical Trial of a Recombinant Adenovirus 5 Vectored COVID-19 Vaccine (Ad5-nCoV) With Two Doses in Healthy Adults
Clinical trial NCT04552366 · COMPLETED
Trial details
- NCT number
- NCT04552366
- Sponsor
- Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-29
- Primary completion
- 2020-12-31
- Enrollment
- 149
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.